BioSpace News Archive

Strategic Acquisition of Tosymra™ (sumatriptan) Nasal Spray and Zembrace® SymTouch® (sumatriptan) Injection Further Expands and Diversifies Company’s Portfolio

Dr. Reddy’s Laboratories Limited, announces the closure of the transaction with Upsher-Smith Laboratories, LLC (Upsher-Smith), pursuant to the satisfactory completion of all customary closing conditions including the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act), as amended.

Results show potential of MultiTAA therapy in combination with chemotherapy as a first-line treatment for patients with pancreatic cancer; potential second-line treatment for chemo-refractory patients